Target intelligence / Profile preview

Abhydrolase domain-containing protein 12B (ABHD12B)

Target
ABHD12B
Molecular classification
Enzyme, Serine hydrolase, Alpha/beta hydrolase domain-containing family
01

Overview

Abhydrolase domain-containing protein 12B (ABHD12B) is a protein coding gene in humans belonging to the alpha/beta hydrolase domain-containing family, similar to its paralog ABHD12[3]. It is predicted to function as a lysophospholipase and monoacylglycerol lipase, participating in lipid metabolic processes such as the catabolism of monoacylglycerol and phosphatidylserine[3]. The protein localizes to the endoplasmic reticulum membrane. Mutations or alterations in ABHD12B have been associated with rare conditions such as aggressive periodontitis and Chanarin-Dorfman syndrome, but its precise physiological and pathological roles are still being elucidated[3]. The protein is structurally related to ABHD12, which is known to be a major lysophosphatidylserine lipase in the brain and is implicated in neurological processes, but there are no published data that directly implicate ABHD12B in these central nervous system functions or in the same set of diseases as ABHD12, such as PHARC[1][3].

Other names
ABHD12BC14orf29BEM46L3Abhydrolase domain-containing 12BAlpha/beta hydrolase domain-containing protein 12Bprotein ABHD12Bc14_5314
02

Mechanism of action

Not established; based on gene family, likely involves inhibition of lysophospholipase or monoacylglycerol lipase activity[3].

03

Biological functions

Predicted lysophospholipase activityPredicted monoacylglycerol lipase activityMonoacylglycerol catabolic processPhosphatidylserine catabolic process[3]
04

Disease associations

Aggressive periodontitisChanarin-Dorfman syndrome[3]
05

Safety considerations

None documented specifically for ABHD12B.
06

Interacting drugs

Not established; no specific drugs or inhibitors documented for ABHD12B as for its paralog ABHD12[3].
07

Biomarkers

None documented specifically for ABHD12B.

Beyond the preview

Go deeper on Abhydrolase domain-containing protein 12B (ABHD12B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abhydrolase domain-containing protein 12B (ABHD12B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call